Limit by date

The first four joint projects of the InfectoGnostics Research Campus successfully completed

The participating partners from four projects funded by the Thüringer Aufbaubank (TAB) as part of the InfectoGnostics Research Campus for Infection Diagnostics held a meeting to present the achieved objectives on Wednesday 4 March. The projects will be concluded at the end of the month. At the same time, the baton was passed at the beginning of February to the already launched BMBF joint project "Pneumonia in Immune Suppression."

The four projects funded by the Thüringer Aufbaubank (TAB) - among others with funds from the pean Regional Development Fund (ERDF) - were started in early October 2013 and have been involved with the on-site diagnosis of tuberculosis, determination of antibiotics in the blood, detection of pathogens in bodies of water and drinking water as well as the identification of biomarkers in animal diseases. "The far-reaching objectives that have been achieved in this rather short project duration are amazing," said Dr. Eike Dazert, Project Manager at TAB. "Supporting the joint research projects to promote, and thus merging academic research with industrial research, has proved worthwhile." For the project partners, the end of the funding does not mean the end of the research. The results and concepts obtained so far are being transferred into applications for forthcoming tenders of the Thuringian Ministry of Economics, Science and Digital Society for the regional innovation and research strategy.

Through the Federal Ministry of Education and Research’s launch of the main phase of the research campus, the joint project “Pneumonia in Immune Suppression” began work in February. In the project, a reliable, fast and non-invasive diagnosis of pneumonia pathogens and their resistance will be developed using optical technologies. "I am delighted that we can now pursue the interdisciplinary approach of the research campus in our key project as well," says Prof. Dr. Jürgen Popp, overall coordinator of the project as well as Board Chairman and spokesperson for InfectoGnostics.